2 completed, 1 withdrawn. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Withdrawn 1 |
| Phase 2 | 1 | Completed 1 |
Follow ritobegron ethyl: new trials by email Literature Review of ritobegron ethyl trials Research Report on ritobegron ethyl
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Long-term Safety and Efficacy of KUC-7483 in Patients With Overactive Bladder KUC-7483 - Overactive Bladder | Phase 3 | Withdrawn | Kissei Pharmaceutical Co., Ltd. | 100 | 2010-07-27 | |
| A Phase II Study of KUC-7483 in Patients With Overactive Bladder KUC-7483, Placebo - Overactive Bladder (OAB) | Phase 2 | Completed | Kissei Pharmaceutical Co., Ltd. | 400 | 2009-09-04 | |
| A Confirmatory Study of KUC-7483 in Patients With Overactive Bladder KUC-7483, Placebo, Tolterodine - Overactive Bladder | Phase 3 | Completed | Kissei Pharmaceutical Co., Ltd. | 750 | 2010-07-27 |
Urinary Bladder, Overactive (3) · Urinary Incontinence, Urge (3)
Kissei Pharmaceutical Co., Ltd. (3)
Japan (3)
Yasuhiro Omori (3)